Aptose Biosciences Files 8-K
Ticker: APTOF · Form: 8-K · Filed: May 20, 2025 · CIK: 882361
Sentiment: neutral
Topics: disclosure, financials
Related Tickers: APTOS
TL;DR
APTOS filed an 8-K on 5/20/25 - check financials & disclosures.
AI Summary
Aptose Biosciences Inc. filed an 8-K on May 20, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Lorus Therapeutics Inc. and Imutec Pharma Inc., is incorporated in Canada and operates in the biological products sector.
Why It Matters
This filing provides important updates and disclosures regarding Aptose Biosciences' financial status and regulatory compliance, which are crucial for investors to assess the company's current standing.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K, which typically contains disclosures and financial statements without immediate significant operational or financial news.
Key Players & Entities
- Aptose Biosciences Inc. (company) — Registrant
- Lorus Therapeutics Inc. (company) — Former company name
- Imutec Pharma Inc (company) — Former company name
- May 20, 2025 (date) — Date of report
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to provide Financial Statements and Exhibits.
What is the exact name of the registrant?
The exact name of the registrant is Aptose Biosciences Inc.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on May 20, 2025.
What were Aptose Biosciences Inc.'s former names?
Aptose Biosciences Inc. was formerly known as Lorus Therapeutics Inc. and Imutec Pharma Inc.
In which jurisdiction is Aptose Biosciences Inc. incorporated?
Aptose Biosciences Inc. is incorporated in Canada.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 20, 2025 regarding Aptose Biosciences Inc. (APTOF).